XTL Biopharmaceuticals Lt... (XTLB)
1.80
-0.06 (-3.23%)
At close: Jan 14, 2025, 3:13 PM
1.86
3.06%
After-hours Jan 14, 2025, 03:13 PM EST
undefined% (undefined)
| Bid | 1.6 |
| Market Cap | 21.55M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | -9.02 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.83 |
| Volume | 3,590 |
| Avg. Volume (20D) | 46,209 |
| Open | 1.85 |
| Previous Close | 1.86 |
| Day's Range | 1.80 - 1.86 |
| 52-Week Range | 0.77 - 4.99 |
| Beta | undefined |
About XTLB
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCD...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 1, 2005
Employees 8
Stock Exchange NASDAQ
Ticker Symbol XTLB
Website https://www.xtlbio.com
10 months ago ·
Source
+128.85%
XTL Biopharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription